BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6665128)

  • 1. Monitoring changes in the blood of patients with multiple sclerosis.
    Jones R; Capildeo R; Preece AW; Luckman NP; Clifford Rose F
    Prog Brain Res; 1983; 59():333-8. PubMed ID: 6665128
    [No Abstract]   [Full Text] [Related]  

  • 2. Linoleic-acid-dependent slowing of erythrocyte sedimentation in multiple sclerosis.
    Mayer M
    Prostaglandins Leukot Essent Fatty Acids; 1991 Dec; 44(4):257-8. PubMed ID: 1815242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linoleate and fatty acid compositions in the serum lipids of Japanese patients with multiple sclerosis.
    Yoshida M; Takase S; Itahara K; Nakanishi T
    Acta Neurol Scand; 1983 Nov; 68(5):362-4. PubMed ID: 6364685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linoleic acid levels in white blood cells, platelets, and serum of multiple sclerosis patients.
    Fisher M; Johnson MH; Natale AM; Levine PH
    Acta Neurol Scand; 1987 Oct; 76(4):241-5. PubMed ID: 3687373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red cell electrophoretic mobility test for early diagnosis of multiple sclerosis.
    Tamblyn CH; Swank RL; Seaman GV; Zukoski CF
    Neurol Res; 1980; 2(1):69-83. PubMed ID: 6114451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma origin of red-cell-membrane changes in multiple sclerosis.
    Seaman GV; Swank RL; Tamblyn CH
    Lancet; 1980 Apr; 1(8174):938. PubMed ID: 6103296
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum linoleic acid in multiple sclerosis.
    Wolfgram F; Myers L; Ellison G; Knipprath W
    Neurology; 1975 Aug; 25(8):786-8. PubMed ID: 1171414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood serum linoleic, linolenic and arachidonic acids in patients with multiple sclerosis.
    Rosnowska M; Piesio B; Cendrowski W
    Acta Med Pol; 1979; 20(3):273-80. PubMed ID: 517165
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell membrane abnormality detected in erythrocytes from patients with multiple sclerosis by partition in two-polymer aqueous-phase systems.
    Van Alstine JM; Brooks DE
    Clin Chem; 1984 Mar; 30(3):441-3. PubMed ID: 6199135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and plasma from patients with multiple sclerosis.
    Cherayil GD
    J Neurol Sci; 1984 Jan; 63(1):1-10. PubMed ID: 6699649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The analysis of the red cell unsaturated fatty acid test for multiple sclerosis using laser cytopherometry.
    Jones R; Preece AW; Luckman NP; Forrester JA
    Phys Med Biol; 1983 Oct; 28(10):1145-51. PubMed ID: 6647546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the erythrocyte-UFA (E-UFA) mobility test for the diagnosis of multiple sclerosis.
    Cuypers J; Reddemann H
    J Neurol Neurosurg Psychiatry; 1980 Nov; 43(11):995-8. PubMed ID: 7441283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnosis of multiple sclerosis.
    Lancet; 1977 Sep; 2(8039):658. PubMed ID: 71468
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of prolonged ingestion of gamma-linolenate by MS patients.
    Field EJ; Joyce G
    Eur Neurol; 1978; 17(2):67-76. PubMed ID: 631143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red-cell-membrane differences in multiple sclerosis are acquired from plasma.
    Seaman GV; Swank RL; Zukoski CF
    Lancet; 1979 May; 1(8126):1139. PubMed ID: 86857
    [No Abstract]   [Full Text] [Related]  

  • 16. Simplified red-cell electrophoretic mobility test for multiple sclerosis.
    Seaman GV; Swank RL; Tamblyn CH; Zukoski CF
    Lancet; 1979 May; 1(8126):1138-9. PubMed ID: 86856
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening of children at risk of multiple sclerosis.
    Forrester JA; Smith WJ
    Lancet; 1977 Aug; 2(8035):453-4. PubMed ID: 70661
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythrocyte electrophoretic mobility test for multiple sclerosis.
    Hawkins SA; Millar JH
    Lancet; 1979 Jan; 1(8108):165-6. PubMed ID: 84195
    [No Abstract]   [Full Text] [Related]  

  • 19. Glutathione peroxidase activity, associated enzymes and substrates in blood cells from patients with multiple sclerosis--effects of antioxidant supplementation.
    Jensen GE; Clausen J
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 7():450-3. PubMed ID: 3776606
    [No Abstract]   [Full Text] [Related]  

  • 20. Levels of linoleate and arachidonate in red blood cells of healthy individuals and patients with multiple sclerosis.
    Homa ST; Belin J; Smith AD; Monro JA; Zilkha KJ
    J Neurol Neurosurg Psychiatry; 1980 Feb; 43(2):106-10. PubMed ID: 7359147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.